Bio-Connect

HLA-A2 antibody [BB7.2] (PE)

GTX80221
GeneTex
TargetHLA-A
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    HLA-A2 antibody [BB7.2] (PE)
  • Delivery Days Customer
    9
  • Antibody Specificity
    This antibody recognizes an epitope at the C-terminus of alpha-2 helix and a turn on one of the underlying beta strands within the human HLA-A2 histocompatibility antigen.
  • Application Supplier Note
    FACS: 20 microl reagent / 100 microl of whole blood or 106 cells in a suspension. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Clone ID
    BB7.2
  • Formulation
    Liquid
  • Gene ID3105
  • Target name
    HLA-A
  • Target description
    major histocompatibility complex, class I, A
  • Target synonyms
    HLA class I histocompatibility antigen, A alpha chain; HLA class I histocompatibility antigen, A-1 alpha chain; HLAA; leukocyte antigen class I-A; MHC class I antigen HLA-A heavy chain
  • Protein IDP01892
  • Protein Name
    HLA class I histocompatibility antigen, A-2 alpha chain
  • Scientific Description
    HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-A alleles have been described. [provided by RefSeq, Jul 2008]
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Neoantigens as potential vaccines in hepatocellular carcinoma. Reparaz D et al., 2022 Feb, J Immunother Cancer
    Read more
  • Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy. Bonaventura P et al., 2022 Jan 28, Sci Adv
    Read more
  • Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells. Wu L et al., 2018 May 8, Proc Natl Acad Sci U S A
    Read more
  • Antigen-specific inhibition of high-avidity T cell target lysis by low-avidity T cells via trogocytosis. Chung B et al., 2014 Aug 7, Cell Rep
    Read more
  • 2D TCR-pMHC-CD8 kinetics determines T-cell responses in a self-antigen-specific TCR system. Liu B et al., 2014 Jan, Eur J Immunol
    Read more